WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2009137340) ALPHA2B AND ALPHA2C AGONISTS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2009/137340    International Application No.:    PCT/US2009/042469
Publication Date: 12.11.2009 International Filing Date: 01.05.2009
IPC:
A61K 31/421 (2006.01), C07D 263/28 (2006.01), A61P 29/02 (2006.01)
Applicants: ALLERGAN, INC. [US/US]; 2525 Dupont Drive T2-7h Irvine, CA 92612 (US) (For All Designated States Except US).
TAKEUCHI, Janet, A. [US/US]; (US) (For US Only).
CHOW, Ken [US/US]; (US) (For US Only).
LI, Ling [US/US]; (US) (For US Only).
WANG, Lilly [US/US]; (US) (For US Only)
Inventors: TAKEUCHI, Janet, A.; (US).
CHOW, Ken; (US).
LI, Ling; (US).
WANG, Lilly; (US)
Agent: FORRESTAL, Kevin; (US)
Priority Data:
61/050,367 05.05.2008 US
Title (EN) ALPHA2B AND ALPHA2C AGONISTS
(FR) AGONISTES D’ALPHA2B ET D’ALPHA2C
Abstract: front page image
(EN)Described herein are compounds that can be useful as bioactive agents. More specifically, the compounds described herein can be useful as both α2B and α2c adrenergic agonists. Methods of synthesis and administration of the compounds are also disclosed. The compounds are N-substituted 2-amino oxazolidines.
(FR)La présente invention concerne des composés qui peuvent se révéler utiles en tant qu’agents bioactifs. De manière plus spécifique, l’invention concerne des composés qui peuvent se révéler utiles tant sous la forme d’agonistes adrénergiques d’α2b que sous la forme d’agonistes adrénergiques d’α2c. Des procédés de synthèse et d’administration des composés sont également décrits. Les composés sont des 2-amino oxazolidines N-substituées.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)